These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Organ-specific genome diversity of replication-competent SARS-CoV-2. Van Cleemput J; van Snippenberg W; Lambrechts L; Dendooven A; D'Onofrio V; Couck L; Trypsteen W; Vanrusselt J; Theuns S; Vereecke N; van den Bosch TPP; Lammens M; Driessen A; Achten R; Bracke KR; Van den Broeck W; Von der Thüsen J; Nauwynck H; Van Dorpe J; Gerlo S; Maes P; Cox J; Vandekerckhove L Nat Commun; 2021 Nov; 12(1):6612. PubMed ID: 34785663 [TBL] [Abstract][Full Text] [Related]
25. Insights into the Replication Kinetics Profiles of Malaysian SARS-CoV-2 Variant Alpha, Beta, Delta, and Omicron in Vero E6 Cell Line. Mohd Zawawi Z; Kalyanasundram J; Mohd Zain R; Mat Ripen A; Basri DF; Yap WB Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408868 [TBL] [Abstract][Full Text] [Related]
26. Long-Read RNA Sequencing Identifies Polyadenylation Elongation and Differential Transcript Usage of Host Transcripts During SARS-CoV-2 Chang JJ; Gleeson J; Rawlinson D; De Paoli-Iseppi R; Zhou C; Mordant FL; Londrigan SL; Clark MB; Subbarao K; Stinear TP; Coin LJM; Pitt ME Front Immunol; 2022; 13():832223. PubMed ID: 35464437 [TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr Virus Lytic Replication Induces ACE2 Expression and Enhances SARS-CoV-2 Pseudotyped Virus Entry in Epithelial Cells. Verma D; Church TM; Swaminathan S J Virol; 2021 Jun; 95(13):e0019221. PubMed ID: 33853968 [TBL] [Abstract][Full Text] [Related]
28. Probenecid inhibits SARS-CoV-2 replication in vivo and in vitro. Murray J; Hogan RJ; Martin DE; Blahunka K; Sancilio FD; Balyan R; Lovern M; Still R; Tripp RA Sci Rep; 2021 Sep; 11(1):18085. PubMed ID: 34508172 [TBL] [Abstract][Full Text] [Related]
29. Propagation of SARS-CoV-2 in Calu-3 Cells to Eliminate Mutations in the Furin Cleavage Site of Spike. Baczenas JJ; Andersen H; Rashid S; Yarmosh D; Puthuveetil N; Parker M; Bradford R; Florence C; Stemple KJ; Lewis MG; O'Connor SL Viruses; 2021 Dec; 13(12):. PubMed ID: 34960703 [TBL] [Abstract][Full Text] [Related]
30. Mathematical modelling of SARS-CoV-2 infection of human and animal host cells reveals differences in the infection rates and delays in viral particle production by infected cells. Bernhauerová V; Lisowski B; Rezelj VV; Vignuzzi M J Theor Biol; 2021 Dec; 531():110895. PubMed ID: 34499915 [TBL] [Abstract][Full Text] [Related]
32. Extracellular and intracellular antiviral effects of ultraviolet A against severe acute respiratory syndrome coronavirus-2 are variant-independent. Leite G; Mehravar S; Pimentel M; Mathur R; Melmed GY; Teagle V; Barlow GM; Rezaie A Photodiagnosis Photodyn Ther; 2024 Jun; 47():104097. PubMed ID: 38677499 [TBL] [Abstract][Full Text] [Related]
33. First isolation and characterization of SARS-CoV-2 from COVID-19 patient of North East India. Jakharia A; Borkakoty B; Pait S; Baruah G; Hazarika R; Biswas D Indian J Pathol Microbiol; 2024; 67(1):133-139. PubMed ID: 38358202 [TBL] [Abstract][Full Text] [Related]
35. Isolation and characterization of severe acute respiratory syndrome coronavirus 2 in Turkey. Pavel STI; Yetiskin H; Aydin G; Holyavkin C; Uygut MA; Dursun ZB; Celik İ; Cevik C; Ozdarendeli A PLoS One; 2020; 15(9):e0238614. PubMed ID: 32936826 [TBL] [Abstract][Full Text] [Related]
36. Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Replication and Tropism in the Lungs, Airways, and Vascular Endothelium of Patients With Fatal Coronavirus Disease 2019: An Autopsy Case Series. Bhatnagar J; Gary J; Reagan-Steiner S; Estetter LB; Tong S; Tao Y; Denison AM; Lee E; DeLeon-Carnes M; Li Y; Uehara A; Paden CR; Leitgeb B; Uyeki TM; Martines RB; Ritter JM; Paddock CD; Shieh WJ; Zaki SR J Infect Dis; 2021 Mar; 223(5):752-764. PubMed ID: 33502471 [TBL] [Abstract][Full Text] [Related]
37. An ultrastructural and genomic study on the SARS-CoV-2 variant B.1.210 circulating during the first wave of COVID-19 pandemic in India. Kumar N; Santhoshkumar R; Prasad P; George AK; Aiyar J; Joshi S; Narayanappa G; Desai AS; Ravi V; Venkataswamy MM Indian J Med Microbiol; 2023; 41():45-52. PubMed ID: 36870749 [TBL] [Abstract][Full Text] [Related]
39. Dried SARS-CoV-2 virus maintains infectivity to Vero E6 cells for up to 48 h. Jang H; Ross TM Vet Microbiol; 2020 Dec; 251():108907. PubMed ID: 33129043 [TBL] [Abstract][Full Text] [Related]
40. Excretion of SARS-CoV-2 through faecal specimens. Zhang Y; Chen C; Song Y; Zhu S; Wang D; Zhang H; Han G; Weng Y; Xu J; Xu J; Yu P; Jiang W; Yang X; Lang Z; Yan D; Wang Y; Song J; Gao GF; Wu G; Xu W Emerg Microbes Infect; 2020 Dec; 9(1):2501-2508. PubMed ID: 33161824 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]